glp-1 drugs and alzheimer's Agonists: Obesity & Breakthrough Insights So… do weight loss drugs

Beutler E

Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum

Miscellaneous clinical studies (Supplementary Table 2

29 By contrast, in a study of Liraglutide for weight reduction (in people with type 2 diabetes) participants lost about 6 percent of their body weight, depending on dose

Both classes are highly effective in reducing cardiovascular events in patients with type 2 diabetes across the spectrum of CVD risk (notably, our prior work comparing across mediation classes suggests that SGLT2is may be even more favorable than GLP-1RAs for some outcomes, and are comparable on others), and we assume that taking both together is likely to be even more beneficial